Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06272747
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-22
First Post:
2024-02-15
Brief Title:
A Phase I Study of XH-S003 in Healthy Volunteers
Sponsor:
S-Infinity Pharmaceuticals Co Ltd
Organization:
S-Infinity Pharmaceuticals Co Ltd
Study Overview
Official Title:
A Phase I Study to Assess the Safety Tolerability and Pharmacokinetics of XH-S003 After Single Ascending Doses Multiple Ascending Doses and Evaluation of Food Effects in Healthy Volunteers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the safety tolerability and pharmacokinetics of XH-S003 in healthy volunteers under SAD Single ascending dose and MAD Multiple ascending dose studies In addition this study evaluates the food effects of XH-S003
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None